Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. End-use
1.2.2. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. End-use outlook
2.3. Competitive Insights
Chapter 3. U.S. In-Vitro Fertilization Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. U.S. In-Vitro Fertilization Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic Landscape
Chapter 4. U.S. In-Vitro Fertilization Market: End-use Estimates & Trend Analysis
4.1. End-use Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. In-Vitro Fertilization Market by End-use Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Clinical
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Academic Research
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Competitive Landscape
5.1. Recent Developments & Impact Analysis, By Key Market Participants
5.2. Company/Competition Categorization
5.3. Vendor Landscape
5.3.1. List of key distributors and channel partners
5.3.2. Key customers
5.3.3. Key company heat map analysis, 2023
5.4. Company Profiles
5.4.1. Leica Microsystems
5.4.1.1. Company overview
5.4.1.2. Financial performance
5.4.1.3. Product benchmarking
5.4.1.4. Strategic initiatives
5.4.2. Olympus Corporation
5.4.2.1. Company overview
5.4.2.2. Financial performance
5.4.2.3. Product benchmarking
5.4.2.4. Strategic initiatives
5.4.3. Nikon Corporation
5.4.3.1. Company overview
5.4.3.2. Financial performance
5.4.3.3. Product benchmarking
5.4.3.4. Strategic initiatives
5.4.4. Sutter Instrument Company
5.4.4.1. Company overview
5.4.4.2. Financial performance
5.4.4.3. Product benchmarking
5.4.4.4. Strategic initiatives
5.4.5. Hamilton Thorne
5.4.5.1. Company overview
5.4.5.2. Financial performance
5.4.5.3. Product benchmarking
5.4.5.4. Strategic initiatives
5.4.6. Zeiss
5.4.6.1. Company overview
5.4.6.2. Financial performance
5.4.6.3. Product benchmarking
5.4.6.4. Strategic initiatives
5.4.7. Meiji Techno
5.4.7.1. Company overview
5.4.7.2. Financial performance
5.4.7.3. Product benchmarking
5.4.7.4. Strategic initiatives
5.4.8. Labomed, Inc.
5.4.8.1. Company overview
5.4.8.2. Financial performance
5.4.8.3. Product benchmarking
5.4.8.4. Strategic initiatives
5.4.9. Narishige Group
5.4.9.1. Company overview
5.4.9.2. Financial performance
5.4.9.3. Product benchmarking
5.4.9.4. Strategic initiatives
5.4.10. Eppendorf SE
5.4.10.1. Company overview
5.4.10.2. Financial performance
5.4.10.3. Product benchmarking
5.4.10.4. Strategic initiatives
5.4.11. Tritech Research, Inc.
5.4.11.1. Company overview
5.4.11.2. Financial performance
5.4.11.3. Product benchmarking
5.4.11.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 U.S. in-vitro fertilization market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. in-vitro fertilization market: market outlook
Fig. 10 U.S. in-vitro fertilization competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. in-vitro fertilization market driver impact
Fig. 16 U.S. in-vitro fertilization market restraint impact
Fig. 17 U.S. in-vitro fertilization market strategic initiatives analysis
Fig. 18 U.S. in-vitro fertilization Market: End-use movement Analysis
Fig. 19 U.S. in-vitro fertilization market: End-use outlook and key takeaways
Fig. 20 Clinical market estimates and forecasts, 2018 - 2030
Fig. 21 Academic research estimates and forecasts, 2018 - 2030